IDH3B Antikörper (AA 151-250) (AbBy Fluor® 680)
-
- Target Alle IDH3B Antikörper anzeigen
- IDH3B (Isocitrate Dehydrogenase 3 (NAD+) beta (IDH3B))
-
Bindungsspezifität
- AA 151-250
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IDH3B Antikörper ist konjugiert mit AbBy Fluor® 680
-
Applikation
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Pig,Horse,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human IDH3B
- Isotyp
- IgG
- Top Product
- Discover our top product IDH3B Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- IDH3B (Isocitrate Dehydrogenase 3 (NAD+) beta (IDH3B))
- Andere Bezeichnung
- IDH3B (IDH3B Produkte)
- Synonyme
- H-IDHB antikoerper, RP46 antikoerper, C78231 antikoerper, zgc:86647 antikoerper, MGC79028 antikoerper, IDH1 antikoerper, IDH3 antikoerper, isocitrate dehydrogenase 3 (NAD(+)) beta antikoerper, isocitrate dehydrogenase 3 (NAD+) beta antikoerper, isocitrate dehydrogenase 3 (NAD+) beta S homeolog antikoerper, IDH3B antikoerper, Idh3B antikoerper, Idh3b antikoerper, idh3b antikoerper, idh3b.S antikoerper
- Hintergrund
-
Synonyms: FLJ11043, H-IDHB, IDH3B, IDH3B_HUMAN, Isocitrate dehydrogenase [NAD] subunit beta, Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial, isocitrate dehydrogenase 3, beta subunit, Isocitric dehydrogenase, Isocitric dehydrogenase subunit beta, MGC903, mitochondrial, NAD+-specic ICDH, NAD+-specic ICDH subunit beta, NAD+-specic isocitrate dehydrogenase b subunit, NAD+-specic isocitrate dehydrogenase beta, OTTHUMP00000030023_ OTTHUMP00000030024, RP46.
Background: Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the beta subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. Three alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008].
-